Ultherapy Boca Raton: What the FDA Clearances Actually Cover

Ultherapy has been cleared by the FDA four times over, and each clearance says something slightly different. Most pages about it quote an indication list that has been out of date since February 2025, and almost none of them quote the one word the FDA itself uses to describe the result. This page works from the clearance documents.

What Ultherapy actually is

Ultherapy is a trade name. The device is the Ulthera System, and the applicant on every clearance is Ulthera, Inc. It delivers micro-focused ultrasound — ultrasound energy focused to a point beneath the skin surface rather than spread across it.

Two things follow from that and are worth understanding before you book Ultherapy in Boca Raton anywhere. The energy is focused, so depth is a deliberate setting rather than a side effect. And because the device is an ultrasound device, it can also see: the Ulthera DeepSEE transducer provides ultrasonic visualisation to a depth of 8 mm below the skin surface. Sources 1 and 3.

It is a Class II device cleared through the 510(k) route. Clearance rests on substantial equivalence to a device already marketed; it is not the same as FDA approval, which applies to Class III devices and requires original human trial data. Any page calling Ultherapy “FDA approved” has the terminology wrong.

The cleared areas, in full

The current clearance is K243035, dated 24 February 2025. It lists the Ulthera System as indicated for use as a non-invasive dermatological aesthetic treatment to:

• lift the eyebrow
• lift lax submental (beneath the chin) and neck tissue, “which can also affect the appearance of lax tissue in the submental and neck regions”
• improve lines and wrinkles of the décolleté
• improve the appearance of skin laxity on the abdomen, anterior arms and posterior arms

Source 3. That is the complete list. Anything outside it is off-label, whoever is offering it.

What was added, and when

The indication list grew over three clearances, which is why pages written at different times disagree with each other.

Sources 1, 2 and 3.

If a page lists only the three facial areas, it was written against the 2014 or 2018 clearance and has not been updated since February 2025.

The word the FDA uses

The 2025 clearance opens with a sentence that most Ultherapy marketing leaves out. The Ulthera System, it says, “is intended to apply focused ultrasound energy to the body to achieve temporary changes in the physical appearance of the skin.” Source 3.

Temporary is the regulator’s word, not a hedge we have added. It is the single most useful thing to know before booking: this is a treatment that changes appearance for a period, not a surgical lift and not a permanent alteration. Any Ultherapy treatment described to you as permanent is being described inaccurately.

Why the imaging matters

The clearances treat the visualisation as a named part of the device rather than a convenience. The stated purpose of the imaging is to visualise the dermal and subdermal layers in order to ensure proper coupling of the transducer to the skin and to confirm appropriate depth of treatment such as to avoid bone. Source 1.

Read that twice, because it is the reason this is a clinical procedure and not a device you operate on yourself. Focused energy placed at the wrong depth is the failure mode the imaging exists to prevent.

What the clearances do not cover

Three limits are worth stating, because a clearance is a narrow document and it is routinely quoted as though it were a broad endorsement.

The area list is the area list. Brow, submental and neck, décolleté, abdomen and arms are what K243035 names. A clearance for those is not a clearance for anywhere else.

Nothing in the clearances promises permanence. The opposite: the current one specifies temporary changes in physical appearance. There is no cleared claim about how long anything lasts.

We are not quoting efficacy numbers here, and that is deliberate. There is published research on micro-focused ultrasound, including long-term studies, but the journal sources were not accessible to us on the day this page was written, so none of it is cited. We would rather publish a page with no efficacy figures than one repeating numbers we have not read in the original. If you want those figures, ask at consultation and they can be gone through with the primary papers in hand.

How Ultherapy is planned at Brazelia MedSpa

Everything above points at one conclusion: with micro-focused ultrasound in Boca Raton, the decisions that matter are depth, area and candidacy — and all three are clinical judgements made with the imaging in front of you, not choices from a menu.

Treatment here is planned at consultation and supervised by Dr. Lazzari’s clinical team. Which areas are appropriate, whether non-surgical skin tightening is the right tool for what is bothering you, and whether something else would serve you better are all settled before anything is scheduled. Sometimes the honest answer is that a different treatment fits better, or that the laxity in question is beyond what a temporary appearance change will satisfy.

Where Ultherapy does fit, it is often one part of a plan rather than the whole of it, sitting alongside RF microneedling, laser resurfacing or collagen stimulators, which work on different structures. The full range sits on the medspa services page.

What you will not get here is a predicted result before anyone has assessed your skin.

Frequently asked questions

Sources and how this page was built

Three FDA 510(k) clearance summaries for the Ulthera System were read directly on 1 October 2026. Nothing on this page is taken from a clinic site, a device brochure or a manufacturer marketing page.